Article Information
History
- May 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Raffaele Palladino1,2,
- Daniele Ceriotti3,
- Damiano De Ambrosi3,
- Marta De Vito3,
- Marco Farsoni3,
- Giuseppina Seminara3 and
- Francesco Barone-Adesi3,4,*
- 1Department of Public Health, University “Federico II” of Naples, Italy
- 2Department of Primary Care and Public Health, Imperial College, London, the UK
- 3Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
- 4CRIMEDIM – Research Center in Emergency and Disaster Medicine, University of Eastern Piedmont, Novara, Italy
- ↵*Corresponding author: francesco.baroneadesi{at}uniupo.it
Posted May 10, 2021.
A quantitative risk-benefit analysis of ChAdOx1 nCoV-19 vaccine among people under 60 in Italy
